Skip to main content
OpenTrials
Completed

NCT Number: NCT05150912

Mnaual Therapy in Treatment of Carpal Tunnel Syndrome

2 groups of patients randomized for the treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Sahar

Cairo, 11431, Egypt

About this study

One group treated with neurodynamic techniques and the the other with the desensitization maneuvers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pain and paresthesia at median nerve distribution ,positive tinel sign and positive phalen sign.

Exclusion criteria

  • Any sensory and/or motor deficit in either ulnar or radial nerve
  • age greater than 55 years .
  • male sex.

Treatment and study plan

Manual therapy

Other

strching neck

Primary outcomes

  1. PAIN and function

    Time frame: after one year

    Boston carpal tunnel questionnaire (BCTQ) measure function and pain

  2. muscle strength

    Time frame: 3 month

    measured by dynamometer to measure cylindrical grip and pincer grip

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Manual Therapy Based on Neurodynamic Techniques Versus Manual Therapy Including Desensitization Maneuvers With One Year Follow-up :Randomized Clinical Trial

Important dates

Study start
2020
Primary completion
2021
Study completion
2023
First posted
Dec 9, 2021
Registry last updated
Jul 19, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.